[1] 孙艺红. 华法林抗凝治疗的中国专家共识 [J]. 中华内科杂志, 2013, 52(1): 76-82.[2] HIRSH J, FUSTER V, ANSELL J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy [J]. Circulation, 2003, 107(12): 1692-711.[3] HOLBROOK A, SCHULMAN S, WITT D M, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e152S-e84S.[4] MANZOOR B S, CHENG W H, LEE J C, et al. Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review [J]. The Annals of pharmacotherapy, 2017, 51(12): 1122-37.[5] CHUA W B, CHEEN H H, KONG M C, et al. Modelling the cost-effectiveness of pharmacist-managed anticoagulation service for older adults with atrial fibrillation in Singapore [J]. International journal of clinical pharmacy, 2016, 38(5): 1230-40.[6] 李舒悦, 王宝彦, 葛卫红,等. 抗凝门诊分级管理的药学模式的实践与探索 [J]. 药学与临床研究, 2021, 29(1): 65-8.[7] 国务院办公厅. 国务院办公厅关于促进“互联网+医疗健康”发展的意见 [EB/OL]. (2018-04-25)http://www.gov.cn/zhengce/content/2018-04/28/content_5286645.htm.